Furthermore, tricyclic and tetracyclic nitrogen bridgehead compounds in complex with AChE were investigated with docking and MD simulations as potential inhibitors for AD treatment by the Decker group, with their strongest inhibitor in the tens of nanomolar regime [204]. This evidence concerns the gene ACHE and Alzheimer disease.